Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 1,060 shares at $3.40 ($4K) on 2021-04-01, disclosed to the SEC on 2021-04-01.
Seasonal sale ($4k) by SVP, Chief Legal Officer — this insider has traded AKBA in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |